Related Experiment Video
Updated: Jul 13, 2026

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
Published on: February 28, 2025
Screening of bifidobacteria with acquired tolerance to human gastrointestinal tract
Ziyu Liu1, Zhijie Jiang, Kang Zhou
1College of Food Science and Nutritional Engineering, China Agricultural University, Room 420, 17# Qinghua East Road, East District, Beijing 100083, China.
Abstract:
Tolerance capabilities of 38 Bifidobacterium strains were achieved by simulating the micro-environment of human gastrointestinal tract using modified MRSC broth (pH 3.0). Fourteen strains of them with high viability were obtained in MRSC with 0.3% bile salts. Sequently, six strains of bifidobacteria with higher survivability were picked in MRSC broth (pH 3.0) supplemented with 1-20mg/ml bile salt. Finally, strain A04 with the optimal ability was chosen for further studies. It had been seen that Bifidobacterium breve A04 had better survival capability to 0.5% pepsin (w/v) or 1% pancreatin (w/v) than other bifidobacteria, and viable bacteria were above 8.00 log cfu/ml after incubation for 24h. Meanwhile, it had higher adhesive capability to HT-29 cells in vitro and average adhesive bacteria numbers reached 12.8+/-0.9 for each HT-29 cell. The results indicated that the ability to tolerate gastroenteric environment and the adhesive capacity to HT-29 cells among Bifidobacterium strains was different. B. breve A04 has several aspects of advantages and may be regarded as potential probiotics.
Related Concept Videos
Microbiota of the Stomach and Small Intestine
Development of Human Microbiota
Probiotics
What is Monogastric Digestion?
Microbiota Modulation by Antibiotics
